Literature DB >> 15504862

Inhibition of adherence and killing of Candida albicans with a 23-Mer peptide (Fn/23) with dual antifungal properties.

Stephen A Klotz1, Nand K Gaur, Jason Rauceo, Douglas F Lake, Y Park, K S Hahm, Peter N Lipke.   

Abstract

Candida albicans adheres to host tissue and then proliferates in order to establish a commensal as well as a pathogenic state. Specific adherence to proteins is provided by several surface adhesins of Candida. Two well-studied proteins, Als1p and Als5p, do not require energy for adherence to occur (dead as well as living cells adhere) and have a multiplier effect of cell-cell aggregation that mediates the formation of microcolonies of Candida cells. The entire process is spontaneous, reversible, and stable for physiologically relevant chemical and physical forces. This adherence process is inhibited by the addition of free peptide ligands, including a 23-mer derived from fibronectin (Fn/23) that binds to the adhesins through H bond formation. Adherence was measured by determining the number of yeast cells that adhered to 90-microm-diameter polyethylene glycol (PEG) beads with a 7-mer peptide (KLRIPSV) synthesized on the surfaces of the beads. The concentration of the Fn/23 peptide that inhibited the adherence of cells to the peptide-coated beads by 50% was 4 to 5 microM, and the magnitudes of adherence were similar regardless of the presence or absence of physiologic salt concentrations. The minimum fungicidal concentration of Fn/23 was 2 to 4 microM in water, but there was no killing in physiologic salt concentrations. Peptides from the C and N termini or the center sequence of Fn/23 had no effect on inhibition of adherence and little effect on fungal viability. The fungicidal effect was similar to that seen with 23-, 19-, and 18-mer peptides derived from porcine myeloid cells, a Helicobacter pylori ribosomal protein, and a hybrid of cecropin and magainin, respectively. However, these fungicidal peptides did not inhibit C. albicans adherence to the peptide-coated PEG beads. This dual property of Fn/23, i.e., inhibition of adherence and killing of C. albicans, may provide important adjuvant effects in the treatment of disease caused by this fungus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504862      PMCID: PMC525394          DOI: 10.1128/AAC.48.11.4337-4341.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Effect of an arginine-glycine-aspartic acid-containing peptide on hematogenous candidal infections in rabbits.

Authors:  S A Klotz; R L Smith; B W Stewart
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans.

Authors:  D G Lee; D H Kim; Y Park; H K Kim; H N Kim; Y K Shin; C H Choi; K S Hahm
Journal:  Biochem Biophys Res Commun       Date:  2001-03-30       Impact factor: 3.575

3.  Overexpression of the Candida albicans ALA1 gene in Saccharomyces cerevisiae results in aggregation following attachment of yeast cells to extracellular matrix proteins, adherence properties similar to those of Candida albicans.

Authors:  N K Gaur; S A Klotz; R L Henderson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  D-cecropin B: proteolytic resistance, lethality for pathogenic fungi and binding properties.

Authors:  A J De Lucca; J M Bland; C B Vigo; T J Jacks; J Peter; T J Walsh
Journal:  Med Mycol       Date:  2000-08       Impact factor: 4.076

5.  Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans.

Authors:  J Andrä; O Berninghausen; M Leippe
Journal:  Med Microbiol Immunol       Date:  2001-04       Impact factor: 3.402

6.  Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins.

Authors:  N K Gaur; S A Klotz
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

Review 8.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Authors:  R I Lehrer; A K Lichtenstein; T Ganz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 9.  Adherence of Candida albicans to host cells.

Authors:  M L Pendrak; S A Klotz
Journal:  FEMS Microbiol Lett       Date:  1995-06-15       Impact factor: 2.742

10.  Adherence and penetration of vascular endothelium by Candida yeasts.

Authors:  S A Klotz; D J Drutz; J L Harrison; M Huppert
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more
  6 in total

1.  Candida albicans Als adhesins have conserved amyloid-forming sequences.

Authors:  Henry N Otoo; Kyeng Gea Lee; Weigang Qiu; Peter N Lipke
Journal:  Eukaryot Cell       Date:  2007-12-14

Review 2.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

3.  Strengthening relationships: amyloids create adhesion nanodomains in yeasts.

Authors:  Peter N Lipke; Melissa C Garcia; David Alsteens; Caleen B Ramsook; Stephen A Klotz; Yves F Dufrêne
Journal:  Trends Microbiol       Date:  2011-11-16       Impact factor: 17.079

4.  Expression and characterization of the flocculin Flo11/Muc1, a Saccharomyces cerevisiae mannoprotein with homotypic properties of adhesion.

Authors:  Lois M Douglas; Li Li; Yang Yang; A M Dranginis
Journal:  Eukaryot Cell       Date:  2007-10-05

5.  Phage display against corneal epithelial cells produced bioactive peptides that inhibit Aspergillus adhesion to the corneas.

Authors:  Ge Zhao; Siyuan Li; Wei Zhao; Kun He; Haijie Xi; Weihua Li; Qingjun Zhou; Yiqiang Wang
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 6.  Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy.

Authors:  Ariane F Lacerda; Patrícia B Pelegrini; Daiane M de Oliveira; Érico A R Vasconcelos; Maria F Grossi-de-Sá
Journal:  Front Microbiol       Date:  2016-02-05       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.